SCIENTIFIC BACKGROUND

KSR2LEPLEPRMC3RMC4RMRAP2NTRK2PCSK1POMCSH2B1SIM1

Monogenic obesity is a very rare, genetically determined form of extreme obesity in early childhood that occurs more frequently in regions with a high proportion of consanguineous marriages. The prevalence is not yet known. Extreme obesity in children and adolescents is defined as a BMI > 99.5 of the age- and sex-specific percentiles, with slightly different trajectories in girls and boys. Within this group, monogenic obesity occurs in 1 to 5% of cases. It usually manifests itself between the first and fourth year of life and is characterized by extreme food-seeking behavior.

 

The feeling of hunger or satiety is controlled by the release of the hormones leptin and insulin, among others, from the adipocytes and beta cells of the pancreas into the bloodstream. Once across the blood/brain barrier, leptin (LEP) interacts with its receptor (LEPR) in the hypothalamus. This results in the activation of proopiomelanocortin (POMC)-producing neurons. The prohormone POMC is converted to alpha-MSH (alpha-melanocyte stimulating hormone) by PCSK1 (proprotein convertase subtilisin/kexin type 1). PCSK1 is a neuroendocrine convertase that processes large precursor proteins, like POMC, into mature bioactive molecules, in this case, alpha-MSH. In a further step, alpha-MSH activates the melanocortin-4 receptor (MC4R), which induces a feeling of satiety.

 

Causative variants in the five genes MC4R, LEP, LEPR, PCSK1, and POMC of the leptin-melanocortin pathway are affected, with heterozygous alterations in the MC4R gene (autosomal dominant inheritance) being the most common cause. Variants in the LEP, LEPR, PCSK1, and POMC genes follow an autosomal recessive mode of inheritance. Outside of this pathway, causative variants in six other genes have been described, sometimes in individual study cohorts (KSR2, MC3R, MRAP2, NTRK2, SH2B1, SIM1).

 

In addition to marked hyperphagia in infancy and early childhood (LEP, LEPR), other clinical abnormalities may include hypogonadotropic hypogonadism (LEP, LEPR), delayed pubertal progression (LEP), reddish hair (POMC), or diabetes insipidus with diarrhea-related malabsorption in the first years of life (PCSK1). Prior to a molecular genetic diagnosis, determination of leptin bioactivity should be performed to differentiate functional leptin deficiency from biologically inactive leptin (with normal leptin levels).

 

Two therapeutic approaches are currently available for the treatment of monogenic obesity. The recombinant analog of human leptin, the protein metreleptin, is used in patients with biologically inactive leptin or leptin deficiency and is administered subcutaneously. The melanocortin-4 receptor agonist setmelanotide is currently in clinical trials for obesity due to POMC deficiency, obesity due to causative variants in the LEP receptor, Prader-Willi syndrome, and others.

 

Although monogenic obesity is very rare, early detection of this disease serves the targeted secondary prevention of comorbidities, also possibly due in part to causal therapy.

 

References
Baldini et Phelan 2019, J Endocrinol 241:R1 / Schnurbein et al. 2018, Monatsschr Kinderheilkd 166:388 / Kohlsdorf et al. 2017, medgen 29:30 / Ramos-Molina et al. 2016, Prog Mol Biol Transl Sci 140:47 / Wabitsch et al. 2015, J Clin Endocrinol Metab 100:3227 / Challis B.G. et Millington G.W.M. 2013, GeneReviews® [Internet]

GENES

KSR2LEPLEPRMC3RMC4RMRAP2NTRK2PCSK1POMCSH2B1SIM1
How to order

LATEST ARTICLES

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more